INDIANA BLOODWORX Trademark

Trademark Overview

On Thursday, August 25, 2022, a trademark application was filed for INDIANA BLOODWORX with the United States Patent and Trademark Office. The USPTO has given the INDIANA BLOODWORX trademark a serial number of 97564892. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Thursday, November 14, 2024. This trademark is owned by Indiana Hemophilia and Thrombosis Center, Inc.. The INDIANA BLOODWORX trademark is filed in the Insurance & Financial Services category with the following description:

Financial administration of reimbursement programs for pharmaceutical services

General Information

Serial Number97564892
Word MarkINDIANA BLOODWORX
Filing DateThursday, August 25, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateThursday, November 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 9, 2024

Trademark Statements

Pseudo MarkINDIANA BLOOD WORKS
Goods and ServicesFinancial administration of reimbursement programs for pharmaceutical services
NOT AVAILABLE"INDIANA"

Classification Information

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, September 14, 2022
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIndiana Hemophilia and Thrombosis Center, Inc.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressIndianapolis, IN 46260
Party NameIndiana Hemophilia and Thrombosis Center, Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressIndianapolis, IN 46260

Trademark Events

Event DateEvent Description
Monday, August 29, 2022NEW APPLICATION ENTERED
Wednesday, September 14, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 12, 2023ASSIGNED TO EXAMINER
Tuesday, June 13, 2023NON-FINAL ACTION WRITTEN
Tuesday, June 13, 2023NON-FINAL ACTION E-MAILED
Tuesday, June 13, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 23, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 28, 2023ASSIGNED TO LIE
Thursday, November 30, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 30, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 30, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, November 30, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, November 30, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, November 30, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, November 30, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, December 20, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 15, 2024SOU TEAS EXTENSION RECEIVED
Friday, August 16, 2024SOU EXTENSION 1 FILED
Friday, August 16, 2024DIVISIONAL REQUEST RECEIVED
Friday, August 16, 2024TEAS STATEMENT OF USE RECEIVED
Friday, August 16, 2024TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, October 29, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 15, 2024DIVISIONAL PROCESSING COMPLETE
Friday, November 15, 2024SOU EXTENSION 1 GRANTED
Friday, November 15, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 5, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

bloodworx indiana pharmaceutical services programs reimbursement administration financial